Nathan T. Jacobs

Nathan T. Jacobs

Auto-generated profile, based on publicly available information

Nathan T. Jacobs

Wolf, Greenfield & Sacks, P.C., Biotechnology Practice Group, 600 Atlantic Avenue, Boston, MA 02210, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
BCBrenda M Calderon
Brenda M Calderon
SDShamika Danzy
Shamika Danzy
GDGabrielle K Delima
Gabrielle K Delima
NJNathan T Jacobs
Nathan T Jacobs
Ketaki GantiKetaki Ganti
Ketaki Ganti
JSJohn Steel
John Steel
The M segment of the 2009 pandemic influenza A virus (IAV) has been implicated in its emergence into human populations. To elucidate the genetic contributions of the M segment to host adaptation, and the underlying mechanisms, we examined a panel of isogenic viruses that carry avian- or human-derived M segments. Avian, but not human, M segments restricted viral growth and transmission in mammalian model systems, and the restricted growth correlated with increased expression of M2 relative to M1. M2 overexpression was associated with intracellular accumulation of autophagosomes, which was alleviated by interference of the viral proton channel activity by amantadine treatment. As M1 and M2 are expressed from the M mRNA through alternative splicing, we separated synonymous and non-synonymous changes that differentiate human and avian M segments and found that dysregulation of gene expression leading to M2 overexpression diminished replication, irrespective of amino acid composition of M1 or M2. Moreover, in spite of efficient replication, virus possessing a human M segment that expressed avian M2 protein at low level did not transmit efficiently. We conclude that (i) determinants of transmission reside in the IAV M2 protein, and that (ii) control of M segment gene expression is a critical aspect of IAV host adaptation needed to prevent M2-mediated dysregulation of vesicular homeostasis. Influenza A virus (IAV) pandemics arise when a virus adapted to a non-human host overcomes species barriers to successfully infect humans and sustain human-to-human transmission. To gauge the adaptive potential and therefore pandemic risk posed by a particular IAV, it is critical to understand the mechanisms underlying viral adaptation to human hosts. Here, we focused on the role of one of IAV’s eight gene segments, the M segment, in host adaptation. Comparing the growth of IAVs with avian- and human-derived M segments in avian and mammalian systems revealed that the avian M segment restricts viral growth specifically in mammalian cells. We show that the mechanism underlying this host range phenotype is a dysregulation of viral gene expression when the avian IAV M segment is transcribed in mammalian cells. In particular, excess production of the M2 protein results in viral interference with cellular functions on which the virus relies. Our results therefore reveal that the use of cellular machinery to control viral gene expression leaves the virus vulnerable to over- or under-production of critical viral gene products in a new host species.

23 February 2022 in Journal of Virology
Verified
Journal Article
Open access
MHMegan R. Hockman
Megan R. Hockman
NJNathan T. Jacobs
Nathan T. Jacobs
BMBernardo Mainou
Bernardo Mainou
KKKatia Koelle
Katia Koelle
ALAnice C. Lowen
Anice C. Lowen
Quantification of reassortment in diverse viral systems is critical to elucidate the implications of genome segmentation for viral evolution. In principle, genome segmentation offers a facile means of genetic exchange between coinfecting viruses.

18 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NJNathan T. Jacobs
Nathan T. Jacobs
JWJeffrey N. Weiser
Jeffrey N. Weiser
Pathogens experience selection at multiple scales, given the need to transmit between hosts and replicate within them. This presents the challenge of cross-scale selective conflict when adaptations to one scale compromise fitness at another, such as mutations that improve transmissibility but make individuals less competitive within hosts. Selection operates differently at these scales, with tight transmission bottlenecks subjecting pathogen populations to genetic drift, and large population sizes within hosts enabling efficient selection for beneficial mutations. Compounding the reduction in diversity by transmission bottlenecks is the occupant-intruder competitive strategy exhibited by some pathogens, where the first variant to colonize a host prevents later arriving variants from contributing to infection, preventing immigration and turning transmission into a “founder takes all” contest. Here, we used multiple modeling approaches to examine how this behavior affects the efficiency of selection for both transmissibility and within- host fitness. We find that in the face of a trade-off, selection for transmissibility is maximized under a tight transmission bottleneck that minimizes within-host competition during colonization. While mutations with increased within-host fitness are favored during within-host replication, an occupant-intruder strategy prevents these mutants from displacing established residents and propagating across the host population, leading to their extinction if they are insufficiently transmissible. Finally, a model of competition on the scale of the host population revealed that competitive exclusion limits the propagation of mutations with improved within-host fitness, unless resident populations can incorporate alleles from intruding variants by recombination. Thus, competitive exclusion may facilitate the improvement and maintenance of pathogen transmissibility, with directional recombination allowing resident populations to mitigate the potential loss of within-host fitness imposed by this occupant-intruder strategy. Author Summary Transmission is a defining feature of infectious diseases, and so a better understanding of how transmissibility evolves is important for improving disease surveillance and prevention. Successful transmission is often achieved by a small number of individuals which, after establishing residency in a host, may prevent newcomers from participating in infection. Here, we use modeling to examine how competitive exclusion of challengers by resident populations affects the balance between within-host competitive ability and transmissibility. We find that competitive exclusion strengthens selection for transmissibility by disproportionately benefitting the first variant to colonize a host and preventing mutants that may be more competitive but less transmissible from displacing established residents. Competitive exclusion also limits the propagation of mutants that improve within-host fitness without reducing transmissibility, however, increasing the advantage of recombination that allows resident populations to acquire beneficial alleles from challengers. Competitive strategies that allow pathogens to “claim ownership” of hosts may thus help pathogen populations maintain transmissibility, with genetic recombination facilitating within-host adaptation through the incorporation of beneficial alleles from challengers.

11 July 2025 in Journal of Law and the Biosciences
Verified
Journal Article
Open access
NJNathan T Jacobs
Nathan T Jacobs
Organisms are complex biological entities that are less easily defined by specific structures or sequences than molecules, nucleic acids, and antibodies. Nor are they necessarily fixed in time or reproducible by repeatable methods, given their capacity for replication and mutation. Like organisms themselves, names and classifications also change over time as scientists better understand extant biodiversity. Taxonomy is the field of evolutionary biology concerned with classifying, naming, and identifying organisms, while phylogenetics concerns organisms’ evolutionary history and relatedness. Here, I review the challenges evolution poses for patentees, using the examples of evolving influenza viruses and bacterial classifications, and Federal Circuit decisions relevant each issue. I conclude that careful consideration of organisms’ evolutionary histories and the systematics underlying their classification in specification drafting allows patentees to: (i) mitigate the impact of scientific disagreement (such as the ‘species problem’ in microbiology) in claim construction; (ii) limit the effects of changing classifications on infringement analysis; (iii) describe generic categories of related organisms to encompass later-arising ones; and (iv) bolster compliance with the written description and enablement requirements of 35 U.S.C. § 112(a). Accordingly, patentees might address the challenges that evolutionary uncertainty poses for organism-centered patents by embracing these areas of evolutionary biology.